---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-22-000030"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2022-02-22T23:59:59+00:00"
generated_at: "2026-06-27T06:13:54.833130+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q4 revenue $84.7M (+104% YoY); FY2021 revenue $271.9M; guides FY2022 rev $365-380M

## Summary
- Q4 2021 revenue $84.7M (+104% YoY); net loss $(31.2)M vs $(5.2)M loss in Q4 2020.
- Full year 2021 revenue $271.9M (+83% YoY); net loss $(107.7)M vs $(18.1)M.
- Subscriptions at 609,000, up 95% YoY; gross margin 73% in Q4 vs 77% a year ago.
- Provides Q1 and FY2022 guidance: FY2022 revenue $365-380M; Adj EBITDA $(30)M to $(20)M.

## SEC filing metadata
- accession: 0001773751-22-000030
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2022-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375122000030/0001773751-22-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375122000030/hims-20220222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-22-000030
- JSON: https://secwatch.observer/filing/0001773751-22-000030.json
- Plain text: https://secwatch.observer/filing/0001773751-22-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.